http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8252047-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c666ccff3af658baee8b615fdf7a27e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86cf3950728d758d96d202d199b353d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63eb1ad5c9d591c63d20824669138676 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82 |
| filingDate | 2011-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bd152a23a2a769c1e4547d585629f74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbbc47d06d20dc225f0e84a123b88c20 |
| publicationDate | 2012-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-8252047-B2 |
| titleOfInvention | Drug-delivery endovascular stent and method for treating restenosis |
| abstract | A radially expandable, endovascular stent designed for placement at a site of vascular injury, for inhibiting restenosis at the site, a method of using, and a method of making the stent. The stent includes a radially expandable body formed of one or more metallic filaments and a liquid-infusible mechanical anchoring layer attached to or formed in outer surface of the filaments. A drug coating in the stent is composed of a substantially polymer-free composition of an anti-restenosis drug, and has a substratum infused in the anchoring layer and a substantially continuous surface stratum of drug that is brought into direct contact with the vessel walls at the vascular site. Thus, the rate of release of the anti-restenosis drug from the surface stratum into said vascular site is determined solely by the composition of said drug coating. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10076591-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9387282-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10064982-B2 |
| priorityDate | 2004-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 264.